Nanotherapeutics Using an HIV-1 Poly A and Transactivator of the HIV-1 LTR-(TAR-) Specific siRNA

HIV-1 replication can be efficiently inhibited by intracellular expression of an siRNA targeting the viral RNA. We used a well-validated siRNA (si510) which targets the poly A/TAR (transactivator of the HIV-1 LTR) site and suppresses viral replication. Nanotechnology holds much potential for impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahajan, Supriya D., Aalinkeel, Ravikumar, Reynolds, Jessica L., Nair, Bindukumar, Sykes, Donald E., Law, Wing-Cheung, Ding, Hong, Bergey, Earl J., Prasad, Paras N., Schwartz, Stanley A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108557/
https://www.ncbi.nlm.nih.gov/pubmed/21660279
http://dx.doi.org/10.4061/2011/719139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108557/
https://www.ncbi.nlm.nih.gov/pubmed/21660279
http://dx.doi.org/10.4061/2011/719139

Ejemplares similares